Binding of adenosine to the A2A receptor on
immune cells blocks the activation and effector functions of anti-tumor immune cells and promotes a regulatory, immune - suppressive phenotype.
The adenosine A ₂ ₐ receptor is the main adenosine receptor expressed on immune cell subsets including T - cells, NK cells and dendritic cells and binding of adenosine to the A ₂ ₐ receptor on
immune cells blocks the activation and effector functions of anti-tumor immune cells and promotes a regulatory, immune - suppressive phenotype.
Not exact matches
By administering a complementary antibody, they
blocked the function of two such
immune checkpoints, whereby different types of endogenous T -
cells were activated.
Commenting on the study for ESMO, Dr Olivier Michielin, head of Personalised Analytical Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland, said: «Omaveloxolone's novel mechanism of action is to
block MDSCs,
cells known to suppress the
immune response.
Transplant recipients take rapamycin because it
blocks the production of a range of different
immune cells.
Based on these ex vivo experiments (in
cells isolated from patients and then exposed to PD - L1
blocking agents outside of the body), they predict that when actual patients are given PD - L1
blocking agents, their viral load at the time will influence the «net» outcome, i.e., whether the blockage boosts or weakens the overall anti-HIV
immune response.
This drug (vedolizumab)
blocks a specific adhesion molecule on the surface of the T -
cell and thereby inhibits
immune cells from binding themselves to receptors present in the intestine, preventing the T -
cells from penetrating the blood vessels in the intestinal tissue.
An unknown component of breast milk appears to kill HIV particles and virus - infected
cells, as well as
blocking HIV transmission in mice with a human
immune system.
Checkpoint inhibitors
block that handshake, which alerts
immune cells to cancer
cells and target them for destruction.
Like a cruel form of mind control, some cancerous tumours can reprogram some
immune cells to «
block» other
immune cells from attacking, leaving the tumour free to grow.
The drug
blocks CTLA - 4, a protein receptor on the surface of T -
cells that serves as a molecular stop sign, preventing the
immune system from going into overdrive.
Patients received a tandem of lenalidomide, a drug that kills tumor
cells,
blocks blood vessel growth, and acts on the
immune system, and dexamethasone, an anti-inflammatory agent, plus one of three new agents:
The patients received biweekly infusions of nivolumab, which is an antibody that
blocks a protein called PD - 1 on the surface of
immune system T
cells.
The drug caused
immune cells called macrophages to eject their cholesterol, an important effect because cholesterol - laden macrophages help trigger artery -
blocking plaques.
The human
immune system wants to produce antibodies that bind to the glycoprotein to stop infection, but the glycans
block immune cells from seeing their targets and developing useful antibodies.
However,
immune cells may be
blocked by inhibitory molecules, which serve as checkpoints to alleviate or «turn off» the
immune system response, Gu explained.
The drug's mechanism of action was entirely new: Instead of attacking cancer
cells (like chemo), or indiscriminately revving up the
immune system (like IL - 2), ipilimumab
blocked a single receptor on one type of
immune cell.
In an effort to
block Aire and prevent the
immune system from killing off T -
cells that might recognize melanoma, researchers tested a compound, an anti-RANKL antibody in mice.
The study, published in the Journal of Neuroscience, found that when microglia, the brain's resident
immune cells, were
blocked, female response to opioid pain medication improved and matched the levels of pain relief normally seen in males.
Scientists had thought that a mother somehow suppresses her
immune responses to the baby, or that the placenta
blocks her
immune cells.
Because previous work in rats and monkeys has found that proteins that
block the costimulatory signal can hold T
cells at bay, Kim Olthoff, a transplant surgeon at the University of Pennsylvania Medical Center in Philadelphia, thought her team could achieve a targeted
immune suppression by getting the transplanted organ itself — rather than proteins injected into the bloodstream — to
block the costimulatory signal.
Allison pioneered
immune checkpoint blockade, an approach that treats the
immune system, rather than the tumor directly, by
blocking molecules on T
cells that shut those attack
cells down, protecting tumors from
immune response.
«Our study reveals a previously unknown mechanism that we might be able to
block to make tumors «visible» again to attacking
immune cells, perhaps in combination with other immunotherapies,» says Miller, also an associate professor in the Department of
Cell Biology.
When the scientists
blocked Treg
cells from accumulating in the fat by targeting a molecule that the
immune cells require, mice no longer developed type 4 diabetes in old age.
«
Blocking immune cell treats new type of age - related diabetes.»
Inhibiting this interaction
blocked the autoimmune process, stopping the microglia from signaling to the peripheral
immune cells and averting myelin damage and inflammation.
Patients in the study were treated with
immune checkpoint inhibitors that
block the activation of PD1, a protein on
immune system T
cells that halts
immune response.
A new class of drugs called
immune checkpoint inhibitors
block molecules on T
cells that shut down
immune response, freeing the
immune system to attack tumors.
«We've known about these
cells blocking immune response for a decade, but haven't been able to shut them down for lack of an identified target,» said the paper's senior author, Larry Kwak, M.D., Ph.D., chair of Lymphoma / Myeloma and director of the Center for Cancer Immunology Research at The University of Texas MD Anderson Cancer Center.
In mice, TGN1412 primarily triggered regulatory T
cells, which
block the action of other T
cells (and thereby reduce autoimmune reactions, wherein
immune cells turn on the body's own
cells).
However, this re-activation is
blocked in most latently - infected
cells by cellular molecules called
immune check - points.
Yipp says the goal is to find a way to
block the clumping of
cells without inhibiting the
immune cells from capturing bugs.
Once they identified this pathway, Hanks and colleagues conducted laboratory tests of a molecule that
blocks melanoma
cells from going stealth, enabling the
immune system to mount a direct attack while also enhancing the function of current immunotherapies such as pembrolizumab and nivolumab.
«Scientists discover how
immune cells die during HIV infection; Identify potential drug to
block AIDS.»
The researchers have shown for the first time that antiviral proteins (the IFITM proteins) produced through the natural
immune response
block the entry of the hepatitis C virus into the
cell.
Researchers led by Van Allen and Choueiri sought an explanation for why some patients with a form of metastatic kidney cancer called clear
cell renal
cell cancer (ccRCC) gain clinical benefit — sometimes durable — from treatment with
immune checkpoint inhibitors that
block the PD - 1 checkpoint, while other patients don't.
The researchers used RNAi to
block three genes: two found in the virus itself and one found in mouse T
cells — the primary
immune system
cells infected by the virus.
«Zika virus may cause microcephaly by hijacking human
immune molecule: Fetal brain model provides first clues on how Zika virus blunts brain development;
blocking mechanism reduces
cell damage.»
Vaccines work by exposing the body to the disease - causing agent or a fragment of it, which primes the
immune system to produce a flood of antibodies that stick to the infecting organism and
block it from entering
cells.
Now, a collaboration between the RIKEN Center for Integrative Medical Science (IMS) and other institutions in Japan and Europe have found that in
immune cells, simply
blocking a transcription factor that leads to differentiation is sufficient to keep
cells in a multipotent stem
cell - like state where they can continue to proliferate and can later differentiate into various
cell types.
The drug tested is an antibody that
blocks a receptor called PD - 1 on the surface of the
immune system's T
cells.
Dagmar Gotthardt and colleagues at the Vetmeduni Vienna now show that
blocking STAT3 in
cells of the
immune system actually leads to increased anti-tumour immunity.
These antibody drugs
block receptors on T
cells that tumors use to hide from the
immune system.
Although drugs to
block the PD - 1 pathway have been developed for cancer patients, they affect all
immune cells, not just HIV - specific ones.
Durvalumab and tremelimumab are drugs in clinical development that
block the PD - 1 / PD - L1 and CTLA - 4 pathways, respectively, and function to restimulate the
immune system to target tumor
cells.
Antibody that
blocks a «do not eat» flag on cancer
cells turns the
immune system against all tumor types
And by actively
blocking the PD - 1 pathway the researchers were able to boost the numbers of HIV - fighting
immune cells in the samples.
A new study shows that a 70 - year - old malaria drug can
block immune cells in the liver so nanoparticles can arrive at their intended tumor site, overcoming a significant hurdle of targeted drug delivery, according to a team of researchers led by Houston Methodist.
By
blocking a specific
cell signaling pathway in lab animals, researchers reversed signs of chronic
immune activation, thereby boosting T -
cell recovery and viral suppression.
Pembrolizumab
blocks the action of the tumor - surface protein PD - 1, which many cancers use to hide themselves from
immune system T
cells.